Aspirin use for primary prevention in older adults
J Am Geriatr Soc
.
2023 Dec;71(12):3927-3929.
doi: 10.1111/jgs.18543.
Epub 2023 Aug 19.
Authors
Russell V Luepker
1
2
,
Jeremy R Van't Hof
2
,
Milton Eder
3
,
John R Finnegan
1
,
Niki Oldenburg
2
,
Sue Duval
2
Affiliations
1
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
2
Cardiovascular Division and Lillehei Heart Institute, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
3
Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
PMID:
37596891
DOI:
10.1111/jgs.18543
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Aged
Aspirin* / therapeutic use
Cardiovascular Diseases* / prevention & control
Humans
Primary Prevention
Risk Factors
Substances
Aspirin
Grants and funding
R01HL126041/NH/NIH HHS/United States
R01HL126041/NH/NIH HHS/United States